Positive environmental modification of depressive phenotype and abnormal hypothalamic-pituitary-adrenal axis activity in female C57BL/6J mice during abstinence from chronic ethanol consumption.

PubWeight™: 0.80‹?›

🔗 View Article (PMC 3722512)

Published in Front Pharmacol on July 23, 2013

Authors

Terence Y Pang1, Xin Du, William A Catchlove, Thibault Renoir, Andrew J Lawrence, Anthony J Hannan

Author Affiliations

1: Behavioural Neurosciences Division, Florey Institute of Neuroscience and Mental Health, University of Melbourne Melbourne, VIC, Australia.

Articles cited by this

Chronic stress, drug use, and vulnerability to addiction. Ann N Y Acad Sci (2008) 4.60

A key role for corticotropin-releasing factor in alcohol dependence. Trends Neurosci (2007) 3.16

Environmental enrichment reverses the effects of maternal separation on stress reactivity. J Neurosci (2002) 2.10

Alcohol self-administration acutely stimulates the hypothalamic-pituitary-adrenal axis, but alcohol dependence leads to a dampened neuroendocrine state. Eur J Neurosci (2008) 1.81

Clinical features associated with glucocorticoid receptor polymorphisms. An overview. Ann N Y Acad Sci (2009) 1.68

Corticosteroid-dependent plasticity mediates compulsive alcohol drinking in rats. J Neurosci (2012) 1.65

Synergistic interaction between nicotine and social rewards in adolescent male rats. Psychopharmacology (Berl) (2009) 1.59

Chronic daily ethanol and withdrawal: 1. Long-term changes in the hypothalamo-pituitary-adrenal axis. Alcohol Clin Exp Res (2000) 1.58

Temporally specific burst in cell proliferation increases hippocampal neurogenesis in protracted abstinence from alcohol. J Neurosci (2004) 1.57

Reversal of cocaine addiction by environmental enrichment. Proc Natl Acad Sci U S A (2008) 1.56

Exercise reverses ethanol inhibition of neural stem cell proliferation. Alcohol (2004) 1.53

Environmental enrichment reduces cocaine seeking and reinstatement induced by cues and stress but not by cocaine. Neuropsychopharmacology (2009) 1.35

The glucocorticoid receptor as a potential target to reduce cocaine abuse. J Neurosci (2003) 1.34

Chronic daily ethanol and withdrawal: 2. Behavioral changes during prolonged abstinence. Alcohol Clin Exp Res (2001) 1.21

Abstinence following alcohol drinking produces depression-like behavior and reduced hippocampal neurogenesis in mice. Neuropsychopharmacology (2008) 1.19

Stress impairs reconsolidation of drug memory via glucocorticoid receptors in the basolateral amygdala. J Neurosci (2008) 1.19

Effect of environmental enrichment on stress related systems in rats. J Neuroendocrinol (2004) 1.18

A review of lifestyle factors that contribute to important pathways associated with major depression: diet, sleep and exercise. J Affect Disord (2013) 1.18

Corticotropin-releasing factor-1 receptor involvement in behavioral neuroadaptation to ethanol: a urocortin1-independent mechanism. Proc Natl Acad Sci U S A (2008) 1.10

Altered serotonin receptor expression is associated with depression-related behavior in the R6/1 transgenic mouse model of Huntington's disease. Hum Mol Genet (2008) 1.07

Glucocorticoids orchestrate divergent effects on mood through adult neurogenesis. J Neurosci (2013) 1.07

Selective increases in regional brain glucocorticoid: a novel effect of chronic alcohol. Neuroscience (2008) 1.03

Effects of galanin on monoaminergic systems and HPA axis: Potential mechanisms underlying the effects of galanin on addiction- and stress-related behaviors. Brain Res (2009) 1.01

DNA methylation of the POMC gene promoter is associated with craving in alcohol dependence. J Neural Transm (Vienna) (2010) 0.97

Effects of environmental enrichment on the incubation of cocaine craving. Neuropharmacology (2012) 0.97

Enhancement of the hypothalamic-pituitary-adrenal axis but not cytokine responses to stress challenges imposed during withdrawal from acute alcohol exposure in Sprague-Dawley rats. Psychopharmacology (Berl) (2011) 0.93

A translational rodent assay of affective biases in depression and antidepressant therapy. Neuropsychopharmacology (2013) 0.92

The European NEAT program: an integrated approach using acamprosate and psychosocial support for the prevention of relapse in alcohol-dependent patients with a statistical modeling of therapy success prediction. Alcohol Clin Exp Res (2002) 0.92

Glucocorticoid receptor and NGFI-A gene expression are induced in the hippocampus after environmental enrichment in adult rats. Brain Res Mol Brain Res (1994) 0.92

Moderate ethanol consumption increases hippocampal cell proliferation and neurogenesis in the adult mouse. Int J Neuropsychopharmacol (2005) 0.91

Persistent increase in hypothalamic arginine vasopressin gene expression during protracted withdrawal from chronic escalating-dose cocaine in rodents. Neuropsychopharmacology (2011) 0.90

Involvement of arginine vasopressin and V1b receptor in alcohol drinking in Sardinian alcohol-preferring rats. Alcohol Clin Exp Res (2011) 0.89

Environmental enrichment rescues female-specific hyperactivity of the hypothalamic-pituitary-adrenal axis in a model of Huntington's disease. Transl Psychiatry (2012) 0.89

Loss of environmental enrichment increases vulnerability to cocaine addiction. Neuropsychopharmacology (2012) 0.86

Drug withdrawal-induced depression: serotonergic and plasticity changes in animal models. Neurosci Biobehav Rev (2011) 0.86

The combined dexamethasone-suppression/CRH-stimulation test in alcoholics during and after acute withdrawal. Alcohol Clin Exp Res (2001) 0.86

Behavioral Studies and Genetic Alterations in Corticotropin-Releasing Hormone (CRH) Neurocircuitry: Insights into Human Psychiatric Disorders. Behav Sci (Basel) (2012) 0.85

Abstinence from moderate alcohol self-administration alters progenitor cell proliferation and differentiation in multiple brain regions of male and female P rats. Alcohol Clin Exp Res (2008) 0.85

D-2 dopamine receptor-mediated inhibition of pro-opiomelanocortin synthesis in rat intermediate lobe. Abolition by pertussis toxin or activators of adenylate cyclase. J Biol Chem (1986) 0.84

Modulation of cellular expression of glucocorticoid receptor and glucocorticoid response element-DNA binding in rat brain during alcohol drinking and withdrawal. J Pharmacol Exp Ther (2002) 0.84

Persisting changes in basolateral amygdala mRNAs after chronic ethanol consumption. Physiol Behav (2008) 0.84

Dopaminergic mediation of physiological changes in proopiomelanocortin messenger ribonucleic acid expression in the neurointermediate lobe of the rat pituitary. Endocrinology (1990) 0.84

Relationship among Dexamethasone Suppression Test, personality disorders and stressful life events in clinical subtypes of major depression: An exploratory study. Ann Gen Hosp Psychiatry (2004) 0.82

Receptor crosstalk: characterization of mice deficient in dopamine D1 and adenosine A2A receptors. Neuropsychopharmacology (2006) 0.82

Influence of environmental enrichment on hypothalamic-pituitary-adrenal (HPA) responses to single-dose nicotine, continuous nicotine by osmotic mini-pumps, and nicotine withdrawal by mecamylamine in male and female rats. Behav Brain Res (2012) 0.82

Effects of chronic alcohol consumption and withdrawal on the response of the male and female hypothalamic-pituitary-adrenal axis to acute immune stress. Brain Res (2012) 0.82

Depression-related behaviours displayed by female C57BL/6J mice during abstinence from chronic ethanol consumption are rescued by wheel-running. Eur J Neurosci (2013) 0.81

Hypothalamic-pituitary-adrenal axis dysfunction as a neurobiological correlate of emotion dysregulation in adolescent suicide. World J Pediatr (2012) 0.79

Environmental enrichment has antidepressant-like action without improving learning and memory deficits in olfactory bulbectomized rats. Neuropharmacology (2011) 0.79

Hypothalamic-pituitary-adrenal system adaptation to detoxification in alcohol-dependent patients is affected by family history of alcoholism. Biol Psychiatry (2003) 0.79

Withdrawal from repeated treatment with ethanol induces a protracted decrease in novelty-seeking behavior and enhancement of environmental habituation in mice. Pharmacol Biochem Behav (2011) 0.78

Distinct receptor subtypes mediate arginine vasopressin-dependent ACTH release and intracellular calcium mobilization in rat pituitary cells. Eur J Pharmacol (2012) 0.77

Addictions and stress: clues for cocaine pharmacotherapies. Curr Pharm Des (2013) 0.77

Articles by these authors

The Unc93b1 mutation 3d disrupts exogenous antigen presentation and signaling via Toll-like receptors 3, 7 and 9. Nat Immunol (2006) 5.83

Genetic analysis of host resistance: Toll-like receptor signaling and immunity at large. Annu Rev Immunol (2006) 5.35

CD36 is a sensor of diacylglycerides. Nature (2005) 5.20

CD14 is required for MyD88-independent LPS signaling. Nat Immunol (2005) 5.20

Impulsivity as a vulnerability marker for substance-use disorders: review of findings from high-risk research, problem gamblers and genetic association studies. Neurosci Biobehav Rev (2008) 4.97

Toll-like receptors 9 and 3 as essential components of innate immune defense against mouse cytomegalovirus infection. Proc Natl Acad Sci U S A (2004) 4.88

Herpes simplex virus encephalitis in human UNC-93B deficiency. Science (2006) 4.26

Enriched environments, experience-dependent plasticity and disorders of the nervous system. Nat Rev Neurosci (2006) 4.08

CD44 is the signaling component of the macrophage migration inhibitory factor-CD74 receptor complex. Immunity (2006) 3.38

Hypersusceptibility to vesicular stomatitis virus infection in Dicer1-deficient mice is due to impaired miR24 and miR93 expression. Immunity (2007) 3.38

MRSA epidemic linked to a quickly spreading colonization and virulence determinant. Nat Med (2012) 2.61

Mutant huntingtin's effects on striatal gene expression in mice recapitulate changes observed in human Huntington's disease brain and do not differ with mutant huntingtin length or wild-type huntingtin dosage. Hum Mol Genet (2007) 2.54

A small-molecule macrophage migration inhibitory factor antagonist protects against glomerulonephritis in lupus-prone NZB/NZW F1 and MRL/lpr mice. J Immunol (2010) 1.91

Gambling near-misses enhance motivation to gamble and recruit win-related brain circuitry. Neuron (2009) 1.90

Relation of addiction genes to hypothalamic gene changes subserving genesis and gratification of a classic instinct, sodium appetite. Proc Natl Acad Sci U S A (2011) 1.89

Antineoplastic mechanisms of niclosamide in acute myelogenous leukemia stem cells: inactivation of the NF-kappaB pathway and generation of reactive oxygen species. Cancer Res (2010) 1.88

Details of Toll-like receptor:adapter interaction revealed by germ-line mutagenesis. Proc Natl Acad Sci U S A (2006) 1.88

Environmental enrichment rescues protein deficits in a mouse model of Huntington's disease, indicating a possible disease mechanism. J Neurosci (2004) 1.75

Environmental enrichment slows disease progression in R6/2 Huntington's disease mice. Ann Neurol (2002) 1.74

MyD88 signaling in nonhematopoietic cells protects mice against induced colitis by regulating specific EGF receptor ligands. Proc Natl Acad Sci U S A (2010) 1.73

Cerebral microbleeds and cognition in patients with symptomatic small vessel disease. Stroke (2013) 1.72

Endosomal TLR signaling is required for anti-nucleic acid and rheumatoid factor autoantibodies in lupus. Proc Natl Acad Sci U S A (2009) 1.70

Enhanced sensitivity to DSS colitis caused by a hypomorphic Mbtps1 mutation disrupting the ATF6-driven unfolded protein response. Proc Natl Acad Sci U S A (2009) 1.69

Pacing or ablation: which is better for paroxysmal atrial fibrillation-related tachycardia-bradycardia syndrome? Pacing Clin Electrophysiol (2014) 1.65

A toll-like receptor 2-responsive lipid effector pathway protects mammals against skin infections with gram-positive bacteria. Infect Immun (2005) 1.55

Effects of enriched environment on animal models of neurodegenerative diseases and psychiatric disorders. Neurobiol Dis (2008) 1.55

Magnetic resonance imaging as an approach towards identifying neuropathological biomarkers for Huntington's disease. Brain Res Rev (2008) 1.55

A tautomerase-null macrophage migration-inhibitory factor (MIF) gene knock-in mouse model reveals that protein interactions and not enzymatic activity mediate MIF-dependent growth regulation. Mol Cell Biol (2009) 1.43

The extracellular matrix gene Frem1 is essential for the normal adhesion of the embryonic epidermis. Proc Natl Acad Sci U S A (2004) 1.41

Dopamine transporter and D2 receptor binding densities in mice prone or resistant to chronic high fat diet-induced obesity. Behav Brain Res (2006) 1.40

An Slfn2 mutation causes lymphoid and myeloid immunodeficiency due to loss of immune cell quiescence. Nat Immunol (2010) 1.39

Discovery of human macrophage migration inhibitory factor (MIF)-CD74 antagonists via virtual screening. J Med Chem (2009) 1.39

Lps2: a new locus required for responses to lipopolysaccharide, revealed by germline mutagenesis and phenotypic screening. J Endotoxin Res (2003) 1.38

A model for familial exudative vitreoretinopathy caused by LPR5 mutations. Hum Mol Genet (2008) 1.36

The neurobiology of brain and cognitive reserve: mental and physical activity as modulators of brain disorders. Prog Neurobiol (2009) 1.35

Simple sequence repeats: genetic modulators of brain function and behavior. Trends Neurosci (2008) 1.33

Homoharringtonine-based induction regimens for patients with de-novo acute myeloid leukaemia: a multicentre, open-label, randomised, controlled phase 3 trial. Lancet Oncol (2013) 1.31

VGLUT3 (vesicular glutamate transporter type 3) contribution to the regulation of serotonergic transmission and anxiety. J Neurosci (2010) 1.29

Environmental enrichment ameliorates a motor coordination deficit in a mouse model of Rett syndrome--Mecp2 gene dosage effects and BDNF expression. Eur J Neurosci (2008) 1.29

The D-dopachrome tautomerase (DDT) gene product is a cytokine and functional homolog of macrophage migration inhibitory factor (MIF). Proc Natl Acad Sci U S A (2011) 1.29

The GABA(B) receptor allosteric modulator CGP7930, like baclofen, reduces operant self-administration of ethanol in alcohol-preferring rats. Neuropharmacology (2006) 1.28

ENU-induced phenovariance in mice: inferences from 587 mutations. BMC Res Notes (2012) 1.28

Dendritic spine pathology and deficits in experience-dependent dendritic plasticity in R6/1 Huntington's disease transgenic mice. Eur J Neurosci (2004) 1.27

R-form LPS, the master key to the activation ofTLR4/MD-2-positive cells. Eur J Immunol (2006) 1.27

The metabotropic glutamate 5 receptor antagonist 3-[(2-methyl-1,3-thiazol-4-yl)ethynyl]-pyridine reduces ethanol self-administration in multiple strains of alcohol-preferring rats and regulates olfactory glutamatergic systems. J Pharmacol Exp Ther (2005) 1.26

Analysis of the MCMV resistome by ENU mutagenesis. Mamm Genome (2006) 1.23

Neurogenesis in the R6/1 transgenic mouse model of Huntington's disease: effects of environmental enrichment. Eur J Neurosci (2006) 1.23

Nature, nurture and neurology: gene-environment interactions in neurodegenerative disease. FEBS Anniversary Prize Lecture delivered on 27 June 2004 at the 29th FEBS Congress in Warsaw. FEBS J (2005) 1.21

Allosteric inhibition of macrophage migration inhibitory factor revealed by ibudilast. Proc Natl Acad Sci U S A (2010) 1.21

Cognitive disorders and neurogenesis deficits in Huntington's disease mice are rescued by fluoxetine. Eur J Neurosci (2005) 1.17

Seasonal variations in notification of active tuberculosis cases in China, 2005-2012. PLoS One (2013) 1.17

Bulk segregation mapping of mutations in closely related strains of mice. Genetics (2010) 1.15

3,4-methylenedioxymethamphetamine self-administration is abolished in serotonin transporter knockout mice. Biol Psychiatry (2007) 1.14

Gene-environment interactions modulating cognitive function and molecular correlates of synaptic plasticity in Huntington's disease transgenic mice. Neurobiol Dis (2007) 1.14

Suppression of heavy drinking and alcohol seeking by a selective ALDH-2 inhibitor. Alcohol Clin Exp Res (2009) 1.13

ENU mutagenesis in mice. Methods Mol Biol (2008) 1.13

Precis on forward genetics in mice. Nat Immunol (2007) 1.13

Enhancement of cognitive function in models of brain disease through environmental enrichment and physical activity. Neuropharmacology (2012) 1.12

Diverse gap junctions modulate distinct mechanisms for fiber cell formation during lens development and cataractogenesis. Development (2006) 1.10

Decreased hippocampal cell proliferation in R6/1 Huntington's mice. Neuroreport (2004) 1.10

Ablation of D1 dopamine receptor-expressing cells generates mice with seizures, dystonia, hyperactivity, and impaired oral behavior. Proc Natl Acad Sci U S A (2007) 1.09

Renovascular hypertension in mice with brain-selective overexpression of AT1a receptors is buffered by increased nitric oxide production in the periphery. Circ Res (2004) 1.08

Are omega-3 fatty acids ineffective for preventing atrial fibrillation recurrence? J Am Coll Cardiol (2013) 1.07

Altered serotonin receptor expression is associated with depression-related behavior in the R6/1 transgenic mouse model of Huntington's disease. Hum Mol Genet (2008) 1.07

Combining domestic and foreign investment to expand tuberculosis control in China. PLoS Med (2010) 1.07

Cyclophosphamide versus mycophenolate mofetil for initial treatment of lupus nephritis. Kidney Int (2013) 1.06

The orexin₁ receptor antagonist SB-334867 dissociates the motivational properties of alcohol and sucrose in rats. Brain Res (2011) 1.06

Is catheter ablation the best way to restore endothelial function? Int J Cardiol (2013) 1.06

Receptor agonists of macrophage migration inhibitory factor. Bioorg Med Chem Lett (2010) 1.06

Deficits in experience-dependent cortical plasticity and sensory-discrimination learning in presymptomatic Huntington's disease mice. J Neurosci (2005) 1.04

System barriers to the evidence-based care of acute coronary syndrome patients in China: qualitative analysis. Circ Cardiovasc Qual Outcomes (2014) 1.03

Limiting cardiac ischemic injury by pharmacological augmentation of macrophage migration inhibitory factor-AMP-activated protein kinase signal transduction. Circulation (2013) 1.02

Assessing appetitive and consummatory phases of ethanol self-administration in C57BL/6J mice under operant conditions: regulation by mGlu5 receptor antagonism. Psychopharmacology (Berl) (2006) 1.01

Brain-derived neurotrophic factor-deficient mice exhibit a hippocampal hyperserotonergic phenotype. Int J Neuropsychopharmacol (2007) 1.01

Activity-dependent regulation of synapse and dendritic spine morphology in developing barrel cortex requires phospholipase C-beta1 signalling. Cereb Cortex (2005) 1.01

Combined antagonism of glutamate mGlu5 and adenosine A2A receptors interact to regulate alcohol-seeking in rats. Int J Neuropsychopharmacol (2007) 1.01

Behavioural and neuroplastic effects of the new-generation antidepressant agomelatine compared to fluoxetine in glucocorticoid receptor-impaired mice. Int J Neuropsychopharmacol (2009) 1.01

The promiscuous mGlu5 receptor--a range of partners for therapeutic possibilities? Trends Pharmacol Sci (2009) 1.00

Analysis of the expression pattern of the BCL11B gene and its relatives in patients with T-cell acute lymphoblastic leukemia. J Hematol Oncol (2010) 1.00

Crystallin {gamma}B-I4F mutant protein binds to {alpha}-crystallin and affects lens transparency. J Biol Chem (2005) 0.99

Optimization of N-benzyl-benzoxazol-2-ones as receptor antagonists of macrophage migration inhibitory factor (MIF). Bioorg Med Chem Lett (2010) 0.99

Wheel running from a juvenile age delays onset of specific motor deficits but does not alter protein aggregate density in a mouse model of Huntington's disease. BMC Neurosci (2008) 0.99

Effects of cysteine proteases on the structural and mechanical properties of collagen fibers. J Biol Chem (2013) 0.98

Regulators of adult neurogenesis in the healthy and diseased brain. Clin Exp Pharmacol Physiol (2007) 0.98

The effect of human tissue factor pathway inhibitor-2 on the growth and metastasis of fibrosarcoma tumors in athymic mice. Blood (2003) 0.98

Olfactory abnormalities in Huntington's disease: decreased plasticity in the primary olfactory cortex of R6/1 transgenic mice and reduced olfactory discrimination in patients. Brain Res (2007) 0.97

New horizons for therapeutics in drug and alcohol abuse. Pharmacol Ther (2009) 0.97

Clozapine reverses schizophrenia-related behaviours in the metabotropic glutamate receptor 5 knockout mouse: association with N-methyl-D-aspartic acid receptor up-regulation. Int J Neuropsychopharmacol (2008) 0.97

The role of BCL11B in hematological malignancy. Exp Hematol Oncol (2012) 0.97

Metabotropic glutamate 5 receptors regulate sensitivity to ethanol in mice. Int J Neuropsychopharmacol (2008) 0.97

Aliskiren in type 2 diabetes and cardiorenal end points. N Engl J Med (2013) 0.97

Life-long hippocampal neurogenesis: environmental, pharmacological and neurochemical modulations. Neurochem Res (2007) 0.97

Alternative expression of TCRζ related genes in patients with chronic myeloid leukemia. J Hematol Oncol (2012) 0.97

Neurocardiac dysregulation and neurogenic arrhythmias in a transgenic mouse model of Huntington's disease. J Physiol (2012) 0.96

Drug repositioning and pharmacophore identification in the discovery of hookworm MIF inhibitors. Chem Biol (2011) 0.96

Sprouting of dopamine terminals and altered dopamine release and uptake in Parkinsonian dyskinaesia. Brain (2008) 0.96

Increased adult hippocampal neurogenesis and abnormal migration of adult-born granule neurons is associated with hippocampal-specific cognitive deficits in phospholipase C-β1 knockout mice. Hippocampus (2010) 0.96

Sex-specific behavioural effects of environmental enrichment in a transgenic mouse model of amyotrophic lateral sclerosis. Eur J Neurosci (2008) 0.95